Ethos Technologies heads into the post-earnings week carrying two colliding forces: a stock up 86% in a month, and shorts bailing out as fast as they can cover.
The earnings print on May 6 was the catalyst. Q1 adjusted EPS of $0.38 smashed the consensus estimate of -$0.11. Revenue of $193M blew past the $144.9M forecast by a wide margin. Management followed that with a full-year revenue guidance raise to $561–$565M, far above the prior $510–$514M range and well ahead of the Street's $512.6M estimate. The stock surged 45% the next session — the biggest single-day reaction in the company's short public life. Then came the giveback: shares fell nearly 14% on May 12 to close at $25.65, likely pressured by the announcement that 25% of eligible shares will be released from lock-up restrictions effective May 14. That overhang is immediate and material.
Short sellers have been in full retreat since the earnings shock. Short interest fell 26% over the week ending May 12, dropping from roughly 2.1 million shares to 1.53 million. The monthly trend is equally clear — positions are down nearly 24% over the past month. The borrow market has eased alongside the covering: cost to borrow dropped from above 10% at the end of April to 6.85% by May 12, down 27% week-on-week. Availability is running at about 81% of short interest — not particularly tight — which means the covering pressure has been orderly rather than a forced squeeze. The ORTEX short score, while still elevated at 60.3, has retreated steadily from its recent peak of 68.0 on May 5. Shorts are uncomfortable here, but they are unwinding in a structured way rather than being squeezed out.
The Street is aligned firmly bullish, and recent moves have pushed targets higher. Barclays raised its price target to $27 from $20 on May 8, maintaining Overweight. Citizens matched that move, lifting to $27 from $21. Both actions came after the earnings print and represent a meaningful upward revision of the bull thesis. The consensus mean target of $23.13 is now modestly below the current price at $25.65, which reflects how quickly the stock has reprinted above where analysts had pencilled in their models just weeks ago — the $13–$15 initiations from JP Morgan and others back in February are stale in the context of current trading. The bull case centres on Ethos's digital distribution model for life insurance, network effects with top-tier carriers, and a track record of growth that the Q1 beat only reinforced. Bears point to a thin operating history, heavy revenue concentration from a small number of carriers, and the difficulty of forecasting a business still operating at an early commercial scale.
Ownership tells an interesting secondary story. The co-founders — Peter Colis and Lingke Wang — together control just over 20% of shares outstanding, and both added meaningfully to their positions earlier this year, with Colis adding nearly 480,000 shares and Wang adding 632,000 around the IPO period. At the same time, GV (Google Ventures) trimmed 1.85 million shares as of March 31, reducing its stake materially. T. Rowe Price and Vanguard both initiated new positions in Q1, adding 764,836 and 549,373 shares respectively — a signal that institutional money is beginning to build real positions rather than just event-trade the name.
The next scheduled event is June 5, with Q2 guidance framing of $114–$118M in revenue already out. With the lock-up release taking effect May 14, the immediate question is not the fundamental story — that has been updated sharply higher — but whether early-stage shareholders use the open window to distribute. That supply dynamic, not the earnings model, is likely to define price action in the near term.
See the live data behind this article on ORTEX.
Open LIFE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
